Black Market Drugs In Mozambique

11 August 1997

Mozambique's government has begun clamping down on black marketmedicines, according to the Inter Press News Service. At least 10% of the $50 million worth of medicines imported by the government is sold on the black market, Inter Press reports, adding that government officials claim more is being sold illegally at private clinics throughout the country.

This has upset stocks of essential drugs, says Chonguissa Moreira, head of the Ministry of Health's Pharmaceutical Department. Hospital and pharmacy staff are stealing drugs, he adds, and some medicines stolen from hospitals are being sold in private clinics where they are sometimes sold without prescription. The Ministry has also suspended five health officials accused of over-invoicing drugs; earlier in the year, 27 other civil servants were suspended for the same reasons.

Some consumers are said to believe it is cheaper and easier to buy black market medicine; to counter this, the government has introduced subsidies for civil servants.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight